These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

611 related items for PubMed ID: 27333751

  • 1. [Anticoagulation for patients with non-valvular atrial fibrillation].
    Mizoguchi T, Yasaka M.
    Nihon Rinsho; 2016 Apr; 74(4):627-33. PubMed ID: 27333751
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Novel Anticoagulants in Atrial Fibrillation: A Primer for the Primary Physician.
    Mookadam M, Shamoun FE, Mookadam F.
    J Am Board Fam Med; 2015 Apr; 28(4):510-22. PubMed ID: 26152444
    [Abstract] [Full Text] [Related]

  • 12. Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population.
    Amin A, Keshishian A, Dina O, Dhamane A, Nadkarni A, Carda E, Russ C, Rosenblatt L, Mardekian J, Yuce H, Baker CL.
    J Thromb Thrombolysis; 2019 Aug; 48(2):240-249. PubMed ID: 30924051
    [Abstract] [Full Text] [Related]

  • 13. Stroke prevention in patients with atrial fibrillation in France: comparative cost-effectiveness of new oral anticoagulants (apixaban, dabigatran, and rivaroxaban), warfarin, and aspirin.
    Lanitis T, Cotté FE, Gaudin AF, Kachaner I, Kongnakorn T, Durand-Zaleski I.
    J Med Econ; 2014 Aug; 17(8):587-98. PubMed ID: 24831811
    [Abstract] [Full Text] [Related]

  • 14. Changing practice of anticoagulation: will target-specific anticoagulants replace warfarin?
    Arepally GM, Ortel TL.
    Annu Rev Med; 2015 Aug; 66():241-53. PubMed ID: 25587651
    [Abstract] [Full Text] [Related]

  • 15. Non-vitamin K Oral Anticoagulants Versus Warfarin for Patients with Atrial Fibrillation: Absolute Benefit and Harm Assessments Yield Novel Insights.
    Kumana CR, Cheung BM, Siu DC, Tse HF, Lauder IJ.
    Cardiovasc Ther; 2016 Apr; 34(2):100-6. PubMed ID: 26727005
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Deng Y, Tong Y, Deng Y, Zou L, Li S, Chen H.
    J Am Heart Assoc; 2019 Jul 16; 8(14):e012540. PubMed ID: 31310583
    [Abstract] [Full Text] [Related]

  • 19. Non-vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin: A retrospective register study.
    Sjögren V, Byström B, Renlund H, Svensson PJ, Oldgren J, Norrving B, Själander A.
    PLoS One; 2017 Jul 16; 12(7):e0181000. PubMed ID: 28700711
    [Abstract] [Full Text] [Related]

  • 20. Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation.
    Di Lullo L, Ronco C, Cozzolino M, Russo D, Russo L, Di Iorio B, De Pascalis A, Barbera V, Galliani M, Vitaliano E, Campana C, Santoboni F, Bellasi A.
    Thromb Res; 2017 Jul 16; 155():38-47. PubMed ID: 28482261
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.